Etoricoxib in Patients With Parkinsonian Disease

NCT07370532 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: L-dopa
DRUG: Etoricoxib

Sponsor

Ihab Elsayed Hassan